Omega Healthcare Investors, Inc. (NYSE:OHI – Get Free Report) has received an average rating of “Moderate Buy” from the fourteen brokerages that are currently covering the stock, MarketBeat reports. Eight research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating on the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $33.65.
OHI has been the topic of several research analyst reports. Scotiabank lifted their price objective on Omega Healthcare Investors from $32.00 to $33.00 and gave the company a “sector perform” rating in a research note on Tuesday. Truist Financial upped their price target on shares of Omega Healthcare Investors from $32.00 to $33.00 and gave the company a “hold” rating in a report on Wednesday, June 26th. JMP Securities reissued a “market perform” rating on shares of Omega Healthcare Investors in a report on Monday, May 6th. Citigroup raised Omega Healthcare Investors from a “neutral” rating to a “buy” rating and increased their target price for the stock from $32.00 to $35.00 in a research report on Friday, March 22nd. Finally, Wells Fargo & Company upgraded Omega Healthcare Investors to a “strong-buy” rating in a research report on Friday, June 14th.
Check Out Our Latest Report on Omega Healthcare Investors
Omega Healthcare Investors Price Performance
Omega Healthcare Investors Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Wednesday, May 15th. Investors of record on Tuesday, April 30th were given a $0.67 dividend. This represents a $2.68 dividend on an annualized basis and a yield of 7.79%. The ex-dividend date of this dividend was Monday, April 29th. Omega Healthcare Investors’s dividend payout ratio is presently 241.44%.
Hedge Funds Weigh In On Omega Healthcare Investors
Hedge funds have recently made changes to their positions in the business. MADDEN SECURITIES Corp boosted its holdings in Omega Healthcare Investors by 4.9% during the second quarter. MADDEN SECURITIES Corp now owns 76,645 shares of the real estate investment trust’s stock worth $2,625,000 after purchasing an additional 3,575 shares during the last quarter. Simplicity Wealth LLC acquired a new position in shares of Omega Healthcare Investors during the 2nd quarter worth about $204,000. CWM LLC grew its holdings in shares of Omega Healthcare Investors by 12.1% in the 2nd quarter. CWM LLC now owns 4,073 shares of the real estate investment trust’s stock valued at $140,000 after acquiring an additional 440 shares in the last quarter. Arden Trust Co raised its holdings in Omega Healthcare Investors by 77.4% during the second quarter. Arden Trust Co now owns 12,810 shares of the real estate investment trust’s stock worth $439,000 after acquiring an additional 5,587 shares in the last quarter. Finally, Versant Capital Management Inc acquired a new position in Omega Healthcare Investors during the second quarter valued at approximately $26,000. 65.25% of the stock is owned by institutional investors.
Omega Healthcare Investors Company Profile
Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.
Featured Stories
- Five stocks we like better than Omega Healthcare Investors
- How to Calculate Options Profits
- Sales Breakout Sends This Semiconductor Stock to Record High
- 3 Warren Buffett Stocks to Buy Now
- Surprise Buying Opportunity on This Dividend Aristocrat
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- New Theme Park Powerhouse: Merger Creates Industry-Leading Stock
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.